Provided by Tiger Trade Technology Pte. Ltd.

Meiragtx Holdings Plc

14.34
-0.2000-1.38%
Post-market: 14.340.00000.00%19:30 EDT
Volume:635.48K
Turnover:9.12M
Market Cap:1.38B
PE:15.28
High:14.85
Open:14.70
Low:14.10
Close:14.54
52wk High:15.35
52wk Low:6.62
Shares:96.04M
Float Shares:53.68M
Volume Ratio:0.73
T/O Rate:1.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9383
EPS(LYR):-1.4199
ROE:72.17%
ROA:38.65%
PB:6.39
PE(LYR):-10.10

Loading ...

MeiraGTx - Enrollment for Phase 2 Gv101 Trial Expected to Begin in Q1 2027

THOMSON REUTERS
·
Aug 11

MeiraGTx Holdings PLC Expected to Post a Loss of 46 Cents a Share - Earnings Preview

Reuters
·
Aug 10

MeiraGTx Grants New Hire 75,000 Stock Options Under Inducement Plan

Reuters
·
Aug 07

MeiraGTx Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 07

Meiragtx CFO, COO Richard Giroux Disposes of 56,000 Shares for $700,560

Reuters
·
Jul 22

MeiraGTx Holdings (MGTX) Secures Oberland Funding, Is The Stock Fully Valued?

Simply Wall St.
·
Jul 11

Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (MGTX) and Sensus Healthcare (SRTS)

TIPRANKS
·
Jul 09

MeiraGTx Royalty Deal Strengthens Funding for Commercial Launch, RBC Says

MT Newswires Live
·
Jul 08

Meiragtx Holdings Price Target Maintained with a $20.00/share by HC Wainwright & Co.

Dow Jones
·
Jul 08

Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (MGTX) and Vera Therapeutics (VERA)

TIPRANKS
·
Jul 08

Meiragtx Chief Scientific Officer, Ophthalmology Stuart Naylor Sells USD 410,811 in Shares

Reuters
·
Jul 08

Top Midday Gainers

MT Newswires Live
·
Jul 08

Meiragtx Rises as Oberland Capital Commits up to $400 Mln for Late-stage Gene Therapies

Reuters
·
Jul 07

Meiragtx Shares up 3.5% Premarket After Co Announces $400 Mln Strategic Investment by Oberland Capital

THOMSON REUTERS
·
Jul 07

Meiragtx Holdings - Oberland Capital Has Right to Purchase Additional $15 Mln in Meiragtx Equity

THOMSON REUTERS
·
Jul 07

Press Release: Meiragtx Announces $400 Million Strategic Investment by Oberland Capital to Support Development and Commercialization of Aav2-haqp1 and Botaretigene Sparoparvovec (bota-vec)

Dow Jones
·
Jul 07

Does MeiraGTx (MGTX) Revenue Slide And Lower Institutional Ownership Reframe Its Long-Term Story?

Simply Wall St.
·
Jun 22

MeiraGTx publishes corporate deck outlining late-stage gene therapy pipeline, manufacturing platform

Reuters
·
Jun 04

MeiraGTx CEO Alexandria Forbes sells 62,000 shares for $568,540

Reuters
·
May 20

Analysts Are Bullish on These Healthcare Stocks: Meiragtx Holdings (MGTX), CalciMedica (CALC)

TIPRANKS
·
May 15